Concepedia
Statistics
Publications
31
Citations
1.8K
H-Index
23
Active since
1982
Affiliations
Pfizer (United States)(Current)
Pfizer (United Kingdom)
University Hospital of Wales
Cardiff University
University of Maryland, Baltimore
Rhys Jones is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and drug discovery.
Publications per year
1982–2024
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 296 citations · Full text
Pharmacy, Infectious Diseases, Pharmacology +15
Smoking and Anesthesia
A. C. Pearce, Rhys Jones · Anesthesiology · 1984 · 160 citations · Full text
Medicine, Perioperative Medicine, Surgery +13
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys Jones, Brandon J. Anson et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 159 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna et al. · Journal of Medicinal Chemistry · 2021 · 117 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
Ben Forbes, Raegan O’Lone, Philippa Pribul Allen et al. · Advanced Drug Delivery Reviews · 2014 · 91 citations · Full text
Pharmacy, Immunology, Toxicology +17
1–5 of 31